BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 25503135)

  • 1. Synthesis of a monofunctional platinum compound and its activity alone and in combination with phytochemicals in ovarian tumor models.
    Arzuman L; Beale P; Yu JQ; Proschogo N; Huq F
    Anticancer Res; 2014 Dec; 34(12):7077-90. PubMed ID: 25503135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergism from combinations of tris(benzimidazole) monochloroplatinum(II) chloride with capsaicin, quercetin, curcumin and cisplatin in human ovarian cancer cell lines.
    Arzuman L; Beale P; Chan C; Yu JQ; Huq F
    Anticancer Res; 2014 Oct; 34(10):5453-64. PubMed ID: 25275041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of Genistein and Cisplatin with Two Designed Monofunctional Platinum Agents in Human Ovarian Tumour Models.
    Arzuman L; Beale P; Proschogo N; Yu JQ; Huq F
    Anticancer Res; 2015 Nov; 35(11):6027-39. PubMed ID: 26504026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of tris(quinoline)monochloroplatinum(II) Chloride and its Activity Alone and in Combination with Capsaicin and Curcumin in Human Ovarian Cancer Cell Lines.
    Arzuman L; Beale P; Yu JQ; Huq F
    Anticancer Res; 2016 Jun; 36(6):2809-18. PubMed ID: 27272792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of trans-bis-(2-hydroxypyridine)dichloroplatinum(II) and its activity in human ovarian tumour models.
    Deqnah N; Yu JQ; Beale P; Fisher K; Huq F
    Anticancer Res; 2012 Jan; 32(1):135-40. PubMed ID: 22213298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monofunctional Platinum-containing Pyridine-based Ligand Acts Synergistically in Combination with the Phytochemicals Curcumin and Quercetin in Human Ovarian Tumour Models.
    Arzuman L; Beale P; Yu JQ; Huq F
    Anticancer Res; 2015 May; 35(5):2783-94. PubMed ID: 25964558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and antitumour activity of a new trinuclear platinum compound [{cis-PtCl(NH3)2μ {trans-Pt(3-hydroxypyridine)2H2N(CH2)5NH2)2}] Cl4 in human ovarian cancer cells.
    Hamad SA; Beale P; Yu JQ; Huq F
    Anticancer Res; 2014 Apr; 34(4):1923-9. PubMed ID: 24692727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinations of platinums and selected phytochemicals as a means of overcoming resistance in ovarian cancer.
    Huq F; Yu JQ; Beale P; Chan C; Arzuman L; Nessa MU; Mazumder ME
    Anticancer Res; 2014 Jan; 34(1):541-5. PubMed ID: 24403514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and activity of a trinuclear platinum complex: [{trans-PtCl(NH3)2}2mu-{trans-Pt(3-hydroxypyridine)2(H2N(CH2)6NH2)2}]Cl4 in ovarian cancer cell lines.
    Tayyem H; Huq F; Yu JQ; Beale P; Fisher K
    ChemMedChem; 2008 Jan; 3(1):145-51. PubMed ID: 17963210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, characterisation, activities, cell uptake and DNA binding of [[trans-PtCl(NH3)2] [mu-(H2N(CH2)6NH2)] [trans-PdCl(NH3)2](NO3)Cl.
    Huq F; Daghriri H; Yu JQ; Tayyem H; Beale P; Zhang M
    Eur J Med Chem; 2004 Nov; 39(11):947-58. PubMed ID: 15501544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on combinations of platinum with paclitaxel and colchicine in ovarian cancer cell lines.
    Yunos NM; Beale P; Yu JQ; Strain D; Huq F
    Anticancer Res; 2010 Oct; 30(10):4025-37. PubMed ID: 21036717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on combination of platinum drugs cisplatin and oxaliplatin with phytochemicals anethole and curcumin in ovarian tumour models.
    Nessa MU; Beale P; Chan C; Yu JQ; Huq F
    Anticancer Res; 2012 Nov; 32(11):4843-50. PubMed ID: 23155250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergism from sequenced combinations of curcumin and epigallocatechin-3-gallate with cisplatin in the killing of human ovarian cancer cells.
    Yunos NM; Beale P; Yu JQ; Huq F
    Anticancer Res; 2011 Apr; 31(4):1131-40. PubMed ID: 21508356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combinations of resveratrol, cisplatin and oxaliplatin applied to human ovarian cancer cells.
    Nessa MU; Beale P; Chan C; Yu JQ; Huq F
    Anticancer Res; 2012 Jan; 32(1):53-9. PubMed ID: 22213288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies on synthesis, activity and binding with DNA of a new trinuclear platinum compound [{trans-PtCl(NH3)2}2{trans-Pt(thiazole)2}{H2N(CH2)(6NH2}2]Cl3(NO3).
    Al-Shuneigat J; Qing Y; Beale P; Fisher K; Huq F
    Med Chem; 2011 Jan; 7(1):1-8. PubMed ID: 21235513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergism from the combination of oxaliplatin with selected phytochemicals in human ovarian cancer cell lines.
    Yunos NM; Beale P; Yu JQ; Huq F
    Anticancer Res; 2011 Dec; 31(12):4283-9. PubMed ID: 22199293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, characterization, activities, cell uptake and DNA binding of trinuclear complex: [{trans-PtCl(NH(3))}(2)mu-{trans-Pt(NH(3))(2-hydroxypyridine)-(H(2)N(CH(2))(6)NH(2))(2)]Cl(4).
    Cheng H; Huq F; Beale P; Fisher K
    Eur J Med Chem; 2005 Aug; 40(8):772-81. PubMed ID: 16122580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the activity of two Trans-planaramine platinum(II) complexes coded as DH4 and DH5 in human ovarian tumour models.
    Deqnah N; Yu JQ; Beale P; Huq F
    Anticancer Res; 2012 Dec; 32(12):5331-6. PubMed ID: 23225434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, characterisation, activities, cell uptake and DNA binding of a trinuclear complex: [[trans-PtCl(NH3)]2mu-[trans-Pd(NH3)(2-hydroxypyridine)-(H2)N(CH2)6NH2)2]Cl4.
    Cheng H; Huq F; Beale P; Fisher K
    Eur J Med Chem; 2006 Jul; 41(7):896-903. PubMed ID: 16730394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and activity of three new trinuclear platinums with cis-geometry for terminal metal centres.
    Hamad SA; Beale P; Yu JQ; Huq F
    J Biomed Sci; 2014 May; 21(1):41. PubMed ID: 24884683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.